What question did this study set out to answer?

Identifying clinical and laboratory factors influencing treatment response in autoimmune hemolytic anemia patients.

December 8, 2025BloodOpen Access

Who needs second-line therapy? predictors of sustained response in autoimmune hemolytic anemia

View Full Paper

Ask AI

Bookmark

Authors

ARA. Rodríguez RodríguezUniversitat de Lleida FCF. ContrerasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Discussion

Member takes

Implication

Retrospective analysis found high-dose corticosteroids and absence of Evans syndrome predict complete response in AIHA patients, highlighting treatment strategies.

Key Points

Identifying clinical and laboratory factors influencing treatment response in autoimmune hemolytic anemia patients.
Conducted a retrospective analysis of adult AIHA patients treated in a tertiary center.
Collected data on demographics, laboratory values, and treatment strategies.
Used logistic regression to identify predictors of complete response and Cox models for time to second-line treatment.
96.9% of patients achieved a hematologic response; 75.4% attained complete response.
High-dose methylprednisolone significantly associated with a higher complete response rate.
33.8% of patients relapsed, with 36.9% requiring second-line therapy.

Cite This Study

Rodríguez et al. (2025) studied this question.

synapsesocial.com/papers/69362f634fa91c937236ddc9 https://doi.org/10.1182/blood-2025-2898

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis found high-dose corticosteroids and absence of Evans syndrome predict complete response in AIHA patients, highlighting treatment strategies.

Who needs second-line therapy? predictors of sustained response in autoimmune hemolytic anemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Who needs second-line therapy? predictors of sustained response in autoimmune hemolytic anemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider